Purine and carnitine metabolism in muscle of patients with Duchenne muscular dystrophy. 1995

F Camiña, and M I Novo-Rodriguez, and S Rodriguez-Segade, and M Castro-Gago
Departamento de Bioquímica, Hospital General de Galicia, Spain.

We determined levels of purines, purine metabolites, related enzymes and carnitine in muscle of 8 untreated Duchenne muscular dystrophy (DMD) patients, 12 allopurinol-treated DMD patients and 12 age-matched controls. Muscle of DMD patients was found to be deficient in ATP, ADP, adenylsuccinate, hypoxanthine, guanine and adenylsuccinate synthetase. In allopurinol-treated DMD patients, mean total adenylate level was only three times less than in controls (versus 14 times less in untreated DMD patients). Mean inosine monophosphate (IMP), adenine, adenosine, inosine, xanthine, guanine, guanosine and uric acid levels were higher in allopurinol-treated patients than in controls, while mean adenylsuccinate levels were higher than in untreated patients. Allopurinol also restored acylcarnitine levels to normal and significantly increased free carnitine levels. These findings strongly support the hypothesis that Duchenne muscular dystrophy involves alterations leading to blockage of the IMP-->purine pathway and that allopurinol treatment favours restoration of purine levels by this route. Furthermore, our results suggest that the observed deficiencies in cell components unrelated to purine metabolism are long-term secondary effects.

UI MeSH Term Description Entries
D009136 Muscular Dystrophies A heterogeneous group of inherited MYOPATHIES, characterized by wasting and weakness of the SKELETAL MUSCLE. They are categorized by the sites of MUSCLE WEAKNESS; AGE OF ONSET; and INHERITANCE PATTERNS. Muscular Dystrophy,Myodystrophica,Myodystrophy,Dystrophies, Muscular,Dystrophy, Muscular,Myodystrophicas,Myodystrophies
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D002331 Carnitine A constituent of STRIATED MUSCLE and LIVER. It is an amino acid derivative and an essential cofactor for fatty acid metabolism. Bicarnesine,L-Carnitine,Levocarnitine,Vitamin BT,L Carnitine
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

F Camiña, and M I Novo-Rodriguez, and S Rodriguez-Segade, and M Castro-Gago
January 1980, Advances in experimental medicine and biology,
F Camiña, and M I Novo-Rodriguez, and S Rodriguez-Segade, and M Castro-Gago
January 1984, Advances in experimental medicine and biology,
F Camiña, and M I Novo-Rodriguez, and S Rodriguez-Segade, and M Castro-Gago
July 1982, Clinica chimica acta; international journal of clinical chemistry,
F Camiña, and M I Novo-Rodriguez, and S Rodriguez-Segade, and M Castro-Gago
April 1979, Clinica chimica acta; international journal of clinical chemistry,
F Camiña, and M I Novo-Rodriguez, and S Rodriguez-Segade, and M Castro-Gago
October 1976, Lancet (London, England),
F Camiña, and M I Novo-Rodriguez, and S Rodriguez-Segade, and M Castro-Gago
May 1980, British medical bulletin,
F Camiña, and M I Novo-Rodriguez, and S Rodriguez-Segade, and M Castro-Gago
August 1987, Biochemical and biophysical research communications,
F Camiña, and M I Novo-Rodriguez, and S Rodriguez-Segade, and M Castro-Gago
March 1976, Archives of neurology,
F Camiña, and M I Novo-Rodriguez, and S Rodriguez-Segade, and M Castro-Gago
February 1994, Chest,
F Camiña, and M I Novo-Rodriguez, and S Rodriguez-Segade, and M Castro-Gago
January 1983, European neurology,
Copied contents to your clipboard!